Related Experiment Video
Updated: Aug 15, 2025

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Oral granulomatosis with polyangiitis a systematic review
Alberto J Peraza Labrador1,2, Luciano H M Valdez3, Nestor R Gonzalez Marin4
1Centro de Odontologia Integral, Acarigua, Venezuela.
Granulomatosis with polyangiitis is a rare inflammatory disease affecting airways and kidneys. Early diagnosis and treatment are crucial for managing this condition and preventing severe outcomes.
Area of Science:
- Rheumatology and Immunology
- Oral Medicine
- Nephrology
Background:
- Granulomatosis with polyangiitis (GPA) is a rare multisystemic inflammatory disease characterized by vasculitis affecting small- and medium-sized vessels.
- GPA typically involves the upper and lower airways, as well as the kidneys, with an unknown etiology potentially linked to genetic predisposition and environmental stimuli.
Approach:
- A comprehensive database search was conducted to gather data on GPA cases.
- Variables analyzed included demographics, disease localization, histopathological findings, antineutrophil cytoplasmic autoantibody (c-ANCA) test results, treatment protocols, and patient follow-up.
Key Points:
- Fifty-two cases were analyzed, predominantly affecting females (57.7%) and white individuals (59.6%), with a mean age of 49.6 years.
- The most frequent oral manifestation was maxillary gingival involvement (28.8%), presenting as "strawberry gingivitis" (61.5%) with pain as a common symptom (50%).
- C-ANCA positivity was observed in 71.2% of cases, and the standard treatment involved prednisone and cyclophosphamide (51.9%).
Conclusions:
- Establishing an early diagnosis and initiating prompt treatment for GPA are essential due to its potential for significant morbidity and mortality.
- Oral clinicians should consider GPA in the differential diagnosis of oral lesions, given its frequent gingival manifestations.
- The study reported an 88.5% survival rate at an average follow-up of 23.6 months, highlighting the importance of timely intervention.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Nephrotic Syndrome II : Assessment and Medical Management